Intas Pharmaceuticals
Sanjay Dhele is an experienced professional in the pharmaceutical industry, currently serving as Associate Vice President at Intas Pharmaceuticals since December 2023. Prior to this, Sanjay held various leadership roles, including Head Site Quality Assurance at Alembic Pharmaceuticals Limited from May 2018 to December 2023 and General Manager of Quality Assurance at Optimus Pharma from May 2016 to May 2018. Previous experience includes positions as Sr. Manager at Hospira, Quality Head at Cadila Healthcare Ltd, and QA Manager at Fresenius Kabi, with a strong focus on operational quality, compliance, and release of finished products. Sanjay holds a Master of Science in Organic Chemistry and has a solid educational foundation in Chemistry, Physics, and Mathematics.
This person is not in the org chart
This person is not in any teams
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.